Moderna says its new booster vaccine candidate is effective against Omicron subvariants
Like other Omicron variants, BA.4 and BA.5 tend to have a milder gradient because they settle less in the lungs. Moderna said Wednesday that its new booster vaccine candidate for Covid-19, which the company hopes will be approved in the fall, is effective against the latest Omicron subvariants. Read alsoVaccines: how BioNTech and Moderna are … Read more